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Poliovirus mutants (PVpi) selected during the persistent infection of human neuroblastoma cells can establish secondary
persistent infections in nonneural HEp-2c cells (I. Pelletier, T. Couderc, S. Borzakian, E. Wyckoff, R. Crainic, E. Ehrenfeld, and
F. Colbe`re-Garapin, 1991, Virology, 180, 729–737). Previous results from our laboratory have also shown that, in the genome
of PVpi S11 derived from the Sabin 1 strain, the genomic region involved in this phenotype contains 11 missense mutations
which map exclusively to the genes encoding the capsid proteins VP1 and VP2. We report here the identification of precise
viral determinants able to confer the capacity to establish persistent infections in HEp-2c cell cultures to the lytic Sabin 1
strain. We used a strategy based on the observation that PVpi, after a few months of persistent infection in HEp-2c cells, tend
to regain a more lytic phenotype in uninfected HEp-2c cell cultures. We constructed mutant viruses carrying only a few
mutations potentially involved in the phenotype of persistence. Two mutations were identified, one corresponding to the
substitution His.Tyr of amino acid 142 of VP2 and another corresponding to the substitution Val.Ile of amino acid 160 of
VP1. Mutants carrying one or the other of the two determinants established persistent infections in HEp-2c cell cultures in
about 20% of the infections. Higher frequencies were obtained with the mutant carrying both determinants (30%), and with
PVpi S11 (63%), indicating that the effects of several determinants can be cumulative. The two determinants are localized on
the capsid surface in a region known to be involved in the interactions between poliovirus and its cell receptor and in fact,
we demonstrate here that in the case of the two persistent mutants, these interactions are modified. © 1998 Academic Press
INTRODUCTION
The model picornavirus, poliovirus (PV), is the etiolog-
ical agent of paralytic poliomyelitis; it has a capsid com-
posed of four proteins VP1 to VP4, enclosing a single
stranded RNA of positive polarity. The lytic cycle of PV
has been studied extensively, and this virus has often
been considered as the prototype of lytic viruses. The
cycle starts with the binding of the virus to the PV recep-
tor (PVR), a protein belonging to the immunoglobulin
superfamily (Koike et al., 1990; Mendelsohn et al., 1989).
The PVR mediates conformational changes in the viral
capsid believed to result in intermediates required for
cell entry (Flore et al., 1990) and PV-induced cytopathic
effects may be due to specific PV–PVR interactions (Mor-
rison et al., 1994).
Although PV is still considered to be a very lytic virus,
it is now known that PV can establish persistent infec-
tions in a variety of neural and nonneural cell lines
(Benton et al., 1996; Carp, 1981; Colbe`re-Garapin et al.,
1989). Mutant viruses called PVpi, isolated from persis-
tently infected human neuroblastoma cells, have the re-
markable property of establishing secondary persistent
infections in nonneural HEp-2c cells (Pelletier et al.,
1991). Since all laboratory PV strains induce cytopathic
effects in HEp-2c cells, we consider a PV strain lytic for
HEp-2c cells when none of these cells survive infection,
or persistent when at least a small proportion of the
culture survives infection and grows in the presence of
virus at high titers (about 107 infectious doses 50 (ID50)
per ml) (Pelletier et al., 1991). In these cultures, after
massive cell lysis, colonies of growing cells can be
isolated as cell clones in which the PV genome can be
detected in 2 to 10% of the cells by in situ hybridization. As
the infection in some of the clones can progress either
toward the lysis or the cure of the cell culture, we have
proposed that the maintenance of persistent infections in
HEp-2c cell cultures is based on an equilibrium between an
abortive and a lytic infection (Borzakian et al., 1992).
We have previously shown that in HEp-2c cells, the
mechanism of the establishment of the persistent infec-
tion differs from that of the maintenance which depends
on the selection of cells expressing a modified pheno-
type (Borzakian et al., 1992).
All HEp-2c cells are susceptible to infection by a lytic
PV strain, independently of the multiplicity of infection
(m.o.i.) and they are also all lysed by PVpi when a m.o.i.
equal to or greater than 0.1 ID50 per cell is used. How-
ever, at a lower m.o.i., PVpi can establish persistent
infections, while the lytic strains cannot. Therefore the
m.o.i. and viral determinants play essential roles during
the establishment phase. In the present study, we fo-
cused on the initial phase of the persistent infection,
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during the first weeks. Determinants involved in PV per-
sistence could be localized by comparing the genomes
of PVpi capable of persistently infecting HEp-2c cell
cultures, to those of their parental strains, which are
always fully lytic in the same cells. We have previously
mapped the determinants responsible for the establish-
ment of persistent infections in HEp-2c cell cultures to a
genomic region covering most of the P1 region and a
part of the 2A protease gene (Calvez et al., 1993). This
region contains 11 missense mutations spread over the
VP1 and VP2 genes, and 8 silent mutations.
We developed a strategy based on the observations
that PVpi, after a few months of persistent infection in
HEp-2c cell cultures, tend to revert to a lytic phenotype
for uninfected HEp-2c cells (Borzakian et al., 1992). Pos-
sibly, some of the mutations of PVpi S11, which derives
from the Sabin 1 (S1) strain (Pelletier et al., 1991), could
have reverted to the S1 genotype. In this study, we show
that this was the case and used this phenomenon to
identify viral determinants responsible for the phenotype
of persistence by constructing viruses carrying only a
few of the mutations. Two mutations, one in the VP1 and
the other in the VP2 gene, were identified as being
involved in this phenotype. Each of them is sufficient, by
itself, to confer the capacity to establish a persistent
infection in HEp-2c cell cultures to the Sabin 1 PV strain.
The corresponding amino acid residues, on the capsid
surface, modify the interactions of persistent PV mutants
with the cell receptor.
RESULTS
Mutations and true reversions during persistent
infection in HEp-2c cells
PVpi have lower titers on nonneural HEp-2c cells than
on neural IMR-32 cells (Pelletier et al., 1991). During
persistent infections in HEp-2c cells by PVpi, the virus
becomes more lytic for uninfected HEp-2c cells after a
few months, suggesting a modification of its genotype
(Borzakian et al., 1992). The increase in the lytic capacity
of these viruses in HEp-2c cells can be evaluated by
comparing their ratio of titers on HEp-2c and on refer-
ence IMR-32 cells to those observed for the initial per-
sistent virus. Indeed, an increased ratio reflects an in-
crease in the lytic capacity of the virus in HEp-2c cells. If
some of the PVpi mutations involved in persistence re-
vert to the genotype of the lytic S1 strain, this phenom-
enon can be used to identify the nucleotide positions
involved in the ability to establish persistent infections in
HEp-2c cell cultures. To look for reversions, four inde-
pendent infections were studied. HEp-2c cells were in-
fected with either PVpi S11 (infections (a) and (b)) or the
S1/11-C1 recombinant (infections (c) and (d)), which car-
ries the S11 genome segment necessary for the persis-
tent phenotype (Calvez et al., 1993). Two to three months
after infection, viruses were collected from the four cell
supernatants, and the ratio of infectious titers on non-
neural HEp-2c and neuroblastoma IMR-32 cells was de-
termined (Table 1). As expected, the mutants selected in
HEp-2c cells after several months of persistent infection
had increased ratios of titers, revealing that they were
more lytic than PVpi in HEp-2c cells. We sequenced the
viral RNAs at the positions of PVpi mutations (Table 2).
True reversions to the lytic S1 strain sequence were
observed. The first one was in the VP2 gene at nucleo-
tide (nt) position 1148, and modified the amino acid 67, in
infections (b) and (d). The second one was in the VP1
gene, at nt position 2957, and modified the amino acid
160, in infection (c). These results suggest that the re-
versions contribute to the increased lytic capacity of the
viruses. In infection (b), other mutations were also ob-
served, whereas in infection (d) the reversion at nt posi-
tion 1148 was the only mutation affecting a position
corresponding to a PVpi mutation. One mutation was
observed in infections (b) and (c) at nt position 1373;
however, this mutation was not a true reversion, since
the corresponding modified amino acid 142 of VP2 is
Asn, compared to His in S1 and Tyr in PVpi S11 (Table 2).
No true reversion was obtained in persistent infection
(a). However, two other mutations were detected at nt
positions 2790 and 3171, altering amino acid residues
104 and 231 of VP1, respectively, which could suppress
some of the determinants of persistence of PVpi S11. The
missense mutation at nt position 3171 was also observed
in infection (b). A silent mutation at nt position 1507 in the
VP2 gene, restoring a wild-type Mahoney nucleotide,
was selected in infections (b) and (c). This confirms
previous results which indicate that a selective pressure
for silent mutations exists for the PV genome (Borzakian
et al., 1993; de la Torre et al., 1992).
Only two true reversions were observed and we there-
fore focused on the corresponding amino acids as po-
tential determinants of persistence. To study the pheno-
TABLE 1
Reversion of PVpi to a Lytic Phenotype for HEp-2c Cell Cultures
during the Persistent Infection in These Cellsa
Virus
Ratio of titers in HEp-2c
and IMR-32 cellsb
Lysis of HEp-2c
cell culturesc
S1 1.8 11
S11 0.025 6
S1/11-C1 0.056 6
S11/(HEp-2c) ad 0.5 1
S11/(HEp-2c) bd 1 1
S1/11-C1/(HEp-2c) cd 1.5 11
S1/11-C1/(HEp-2c) dd 4 11
a The means of two independent experiments are given.
b Titers are expressed as ID50 per milliliter.
c The lysis of HEp-2c cell cultures is scored 6, 1, or 11 when the
ratio of titers in HEp-2c and IMR-32 cells, used as reference cells, was
below 0.1, between 0.1 and 1, or above 1, respectively.
d Virus populations from persistent infections in HEp-2c cell cultures
were collected 2 to 3 months after infection.
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type that these reversions conferred to the virus in
HEp-2c cells, each of the two point mutations was intro-
duced separately into the cDNA of S1/S11-C1. The re-
sulting cDNA in the S1/11-C1(1V) and S1/11-C1(2D) re-
combinants carried the reversions at nt position 2957,
corresponding to amino acid 160 of VP1 (I1160V, abbre-
viated as (1V)) and at nt position 1148 corresponding to
amino acid 67 of VP2 (N2067D, abbreviated as (2D)),
respectively (Fig. 1A). The former decreased the score of
persistence from 100 to 21%. This confirmed the impor-
tance of residue 160 of VP1 in the establishment of a
persistent infection. The virus resulting from the latter
construction was not viable even when three indepen-
dent clonings were attempted. However, this determi-
nant was studied further because of the reversions ob-
served in infections (b) and (d) at this position.
Localization of mutations involved in persistence in
HEp-2c cell cultures
Our previous results suggested that at least one
determinant from each of the two genes VP2 and VP1
was necessary to efficiently establish persistent infec-
tion (Calvez et al., 1993), and we therefore focused first
on the study of the association of determinants
present in both genes. Thus, to determine if each of
the two S11 determinants are sufficient when in com-
bination with all of the determinants of the other gene,
two recombinants were constructed as shown in Fig.
1B. The first one, named S1/11(2N-VP1), carried the
D2067N S11 determinant (abbreviated (2N)) in the VP2
gene and all of the S11 determinants in the VP1 gene.
The corresponding virus was able to establish a per-
sistent infection in HEp-2c cell cultures with a score of
43%. This result revealed that when all the S11 deter-
minants were present in the VP1 gene, the S11 deter-
minant (2N) alone in the VP2 gene was sufficient for
persistent infection. The second recombinant virus,
named S1/11(VP2-1I), carried the V1160I determinant
in VP1 (abbreviated as (1I)) and all of the S11 deter-
minants in the VP2 gene. Surprisingly, this virus was
also able to persist in HEp-2c cell cultures with a
similar score, suggesting that more than one combi-
nation is possible and that both determinants (2N) and
(1I) may be involved in persistence. An S1 recombinant
carrying only the two S11 mutations was constructed
(Fig. 1B). The resulting virus, S1(2N-1I), was lytic in
HEp-2c cells, since no persistent infection was ob-
served in a total of 32 infected cultures. Therefore, we
tried to identify the VP2 determinants which, in the
presence of (1I) in VP1, conferred the persistent phe-
notype to the virus, as there are only 4 missense and
3 silent mutations in the VP2 gene compared to 10
mutations in the VP1 gene.
Identification of determinants sufficient for PV
persistence in HEp-2c cell cultures
To identify the determinants in the VP2 gene neces-
sary for persistence in the presence of the (1I) mutation,
we first eliminated the three silent mutations present in
the VP2 gene (Fig. 2A). As expected, the corresponding
TABLE 2
True Reversions and Other Mutations Observed in the PVpi Genome during Persistent Infection in HEp-2c Cell Cultures
with S11 (Infections (a) and (b)) and with S1/11-C1 (Infections (c) and (d))a
Gene
Nucleotide Amino Acid
Positionb S1 S11
S11/(HEp-2c) S1/11-C1/(HEp-2c)
Postionc S1 S11
S11/(HEp-2c) S1/11-C1/(HEp-2c)
(a) (b) (c) (d) (a) (b) (c) (d)
VP2 1148 G A A A3G A A3G 67 D N N N3D N N3D
1370 A G G G G G 141 M V V V V V
1373 C U U U3A U3A U 142 H Y Y Y3N Y3N Y
1452 C U U U U U 168 T I I I I I
1507 A A A A3G A3G A 191 L L L L L L
VP1 2544 C U U U U U 22 T M M M M M
2607 C U U U U U 43 A V V V V V
2781 A G G G G G 101 K R R R R R
2790 T T T3C T T T 104 L L L3P L L L
2795 A G G G G G 106 T A A A A A
2957 G A A A A3G A 160 V I I I I3V I
3147 C U U U U U 223 A V V V V V
3171 C C C3T C3 T C C 231 A A A3V A3V A A
3234 A G G G G G 252 K R R R R R
a Only the sequence around the positions of mutations specific to the S11 genome was determined. True reversions are indicated in bold and
underlined. Mutations not corresponding to S11 mutations are in italics.
b Number corresponding to the nucleotide position within the entire genome.
c Number corresponding to the amino acid position within the individual protein.
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virus S1(2NVYI-1I) had a similar score of persistence in
HEp-2c cells to that of S1/11(VP2-1I), indicating that si-
lent mutations do not contribute to the phenotype of
persistence. Three other mutants were constructed (Fig.
2A). S1(2NI-1I) carried the T2168I (abbreviated as (2I))
substitution of S11 in addition to the previously identified
(2N) and (1I) residues. This virus was able to establish
persistent infections with a score of 12%. Thus (2I) may
contribute to persistence in this context. The second
mutant carried the S11 determinant H2142Y (abbreviated
as (2Y)) in addition to the three substitutions (2N), (2I),
and (1I). This virus established persistent infections in
HEp-2c cell cultures at a frequency comparable to that of
S1/11-(VP2-1I) (Figs. 1B and 2A). The third recombinant
carried the same substitutions, except for the (2I) deter-
minant. The virus obtained was persistent in HEp-2c
cells, indicating that, in the presence of the (2Y) substi-
tution, (2I) was not essential for persistence (Fig. 2A).
FIG. 1. Constructions to detect the effect of S1 residues at the amino acid positions 67 of VP2 and 160 of VP1 (A) and the effect of S11 residues
at the same positions (B) in the phenotype of persistence. Enlarged genome segments of the P1 region and part of the 2A gene, showing the genotype
of pVS1 and the chimeras with S1/11-C1 which carry the missense mutations (large vertical bars) and silent mutations (short vertical bars) of S11. S1
sequences are represented in white and S11 sequences are in gray. White circles indicate S1 mutations; gray circles indicate S11 mutations. The
mutations are indicated above the circles, with the letter corresponding to the substituted amino acid, the number of the capsid protein and that of
the amino acid, and the letter of the amino acid corresponding to the mutated codon. The abbreviations used in the text are indicated in parentheses
after each mutation name. The restriction sites used to construct the chimeric viruses are indicated. Names of the mutants—the mutations are
mentioned in parentheses: for point mutations, the number of the capsid protein is given with the letter corresponding to the modified amino acid;
when the entire VP1 or VP2 gene of S11 was introduced, the name of the capsid protein is given in full. The score of persistent infection in HEp-2c
cell cultures is expressed as a percentage. The number of persistently infected cultures versus the total number of infected cultures is given in
parentheses.
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Further mutants were constructed to investigate the
role of each of the three mutations in the phenotype of
persistence. S1(2VY-1I) (Fig. 2B) did not carry determi-
nant (2N) but included (2Y), (1I), and (2V), which was
investigated because of its proximity to (2Y) (amino acid
positions 141 and 142 of VP2, respectively). This virus
had a high score of persistence (Fig. 2B), revealing that
the (2N) determinant was not required in this context.
S1(2Y-1I) was constructed, carrying only determinants
(2Y) and (1I). It established persistent infections in
HEp-2c cell cultures since growing cell colonies were
observed in about one third of the wells despite the
presence of virus (Fig. 3). Thus, the (2V) substitution was
not essential. Under the same conditions, the S1 strain
never gave a single colony of persistently infected cells,
even when cultures were refed for 8 weeks after infec-
tion, demonstrating the crucial role played by PVpi de-
terminants during the first weeks of infection. The entire
P1 region of the S1(2Y-1I) RNA was sequenced and no
supplementary mutations were found.
Four weeks after infection with S1(2Y-1I), the presence
of both PVpi mutations was checked in two HEp-2c cell
FIG. 2. Constructions of point mutants carrying (A) or not carrying (B) the S11 residues at amino acid position 67 of VP2. Enlarged genome segments
(P1 region) illustrate the genotype of pVS1 mutants. Gray circles indicate S11 mutations, introduced by in vitro mutagenesis as described under
Materials and Methods. The nomenclature of the mutated cDNAs and that of the mutations is the same as in Fig. 1. The capacity of the corresponding
mutants to persistently infect HEp-2c cell cultures is given as in Fig. 1.
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cultures in which persistent infections were established
and in six cultures in which the infection was entirely
lytic. In all cases, PVpi mutations were clearly detected,
without any reversions at these positions, even in the
cultures in which the virus failed to establish a persistent
infection (results not shown).
Independent recombinants carrying determinants (2Y)
or (1I) were constructed and two independent cDNA
clones of each construction, S1(2Y) and S1(1I), were
used for two independent transfections. Surprisingly,
both types of point mutants carrying either determinant
(2Y) or (1I) were able to establish persistent infections in
HEp-2c cell cultures, albeit with a lower score (about
20%) than was seen with the double mutant S1(2Y-1I)
(Figs. 2B and 3). The two viruses isolated for each point
mutant S1(2Y) and S1(1I) gave similar results. The RNA in
the P1 region of one of each point mutant was entirely
sequenced and no additional mutations were found. To
eliminate the possibility that the point mutations just
increased the probability of obtaining a virus with a
persistent phenotype by favoring the selection of addi-
tional mutations as one of the required mutations had
already been introduced, supernatants were collected
after 3 weeks of persistent infection with these mutants.
These viruses were used to infect HEp-2c cells and their
scores were similar or slightly lower than the scores
obtained with the initial point mutants, suggesting that
the essential mutations for the establishment were the
expected initial mutations which we had introduced by
cloning (data not shown). This is consistent with our
strategy, which is based on the observation that persis-
tent mutants tend to recover a lytic phenotype during
persistent infection of HEp-2c cells. Therefore, a single
amino acid change at position 142 in the VP2 protein or
160 in the VP1 protein was sufficient to confer the ability
to persist in HEp-2c cell cultures to the S1 strain.
To verify that the multiplication of the point mutants
S1(2Y), S1(1I), and S1(2Y-1I) was not severely impaired in
HEp-2c cells, the virus yields were titered after infection
of HEp-2c cells at m.o.i. of 4 and 1024 ID50/cell. At 6, 8,
and 24 h after infection, the virus yields obtained at the
high multiplicity were similar for the mutants and the
parental S1 strain (.108 ID50/ml). At the low m.o.i., cor-
responding to the conditions required for the establish-
ment of a persistent infection, the virus yields of the point
mutants 48 h after infection were not as high as those of
S1 (107 ID50/ml) but were close to 10
6 ID50/ml (results not
shown). Therefore, the growth of the point mutants dur-
ing the first 2 days of infection increased the virus to cell
ratio from 1024 up to about 1 ID50/cell. These results
indicate that the low m.o.i. was crucial only during the
first hours of infection, because a m.o.i. of 1 ID50 per cell
at the time of infection is not compatible with the estab-
lishment of a persistent infection. Moreover, it indicates
that, even when a low m.o.i. was used, the cells had very
little chance of escaping infection.
Modification of virus binding to PVR
The viral determinants involved in persistence are
located in the capsid proteins. The first determinant (2Y)
which, by itself, confers the phenotype of persistence to
S1, corresponds to a His.Tyr substitution at amino acid
position 142 of VP2. The second, (1I), corresponds to a
Val.Ile substitution at amino acid position 160 of VP1.
Both these residues are on the capsid surface, as de-
duced from the three dimensional structure of PV (Hogle
et al., 1985). Position 142 of VP2 is in the E–F loop of VP2,
in the canyon, and may interact directly with the PVR.
Position 160 of VP1 is in the b strand E, near the E–F
loop, at the interface between protomers, above the
hydrophobic pocket which is supposed to contain a
sphingosine molecule in the mature virion of the wild-
type Mahoney strain (Colston and Racaniello, 1995; Fil-
man et al., 1989). In fact, this determinant could alter the
stability and/or the plasticity of the viral capsid for per-
sistent mutants, which could modify their interactions
with the PVR. Thus, we measured the binding of radio-
active S1(1I), S1(2Y), and the corresponding double mu-
tant S1(1I-2Y) and compared it to the binding of both the
lytic S1 and the persistent S1/11-C1 and S11 viruses (Fig.
4). As expected, the kinetics of adsorption of the S11
virus and the S1/11-C1 recombinant, which carried the
same determinants as S11 in the capsid protein region,
FIG. 3. Colonies of HEp-2c cells persistently infected by S1 mutants and stained 8 weeks after infection. Cultures were infected as described under
Materials and Methods. The name of the recombinant viruses and mutants are as in Figs. 1 and 2. S1 was used as a negative control; S11 and
S1/11-C1 were used as positive controls. Colonies appear in black in several wells infected with each of the three point mutants.
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were similar. Their binding kinetics were also similar to
those of the lytic S1 strain. In contrast, the two point
mutants and the corresponding double mutant adsorbed
more efficiently to PVR than the lytic S1 strain. The effect
of the two mutations seems to be additive since the
adsorption of the double mutant was more efficient than
that of the two point mutants S1(1I) and S1(2Y). Thus, the
two point mutations modified the adsorption of the S1
strain to PVR, although they seemed to have no effect
within the context of S11 or S1/11-C1 in which several
other mutations may alter the global structure of the
capsid.
Enhanced elution and receptor-induced capsid
transitions with a single capsid substitution
After the binding step of PV to PVR, the formation of
135S particles, resulting from conformational changes
of 160S particles, is believed to be a possible indicator
of the viral uncoating process (Flore et al., 1990). A
fraction of these particles are released from the cells,
corresponding to the elution process. Since the pro-
portion of these released particles could influence the
viral cycle of the persistent mutants, we measured the
percentage of viruses which remained cell-associated
when the temperature was shifted up to 37°C for
various times after attachment (Fig. 5). The difficulty of
comparing the elution of viruses which had differ-
ences in the efficiency of adsorption was circum-
vented by expressing the values as a percentage of
the total cell-associated radioactivity prior to incuba-
tion at 37°C. The results shown in Fig. 5 indicate that
S1(1I) and S1(2Y-1I) had elution kinetics which differed
greatly from those observed for S1/11-C1 and S1(2Y)
which were similar to that of S1 (with a maximum
standard error of the mean of 4%). In fact, S1(1I) and
S1(2Y-1I) eluted much faster and to a much greater
extent than the other three viruses. Thus the mutation
(1I) seemed to be involved in the modification of the
elution profile of the S1(2Y-1I) mutant although it was
not effective in the context of the S1/11-C1 recombi-
nant.
As each of the single point mutants was able to
establish persistent infections, it was decided to focus
on these two viruses in order to try and elucidate the
mechanisms underlying the establishment of persis-
tent infections. The above experiments were therefore
repeated with the S1, S1(1I), and S1(2Y) viruses, but
the cell-associated particles were analyzed by su-
crose gradient ultracentrifugation, following cell lysis.
The kinetics of the conformational modification of the
160S particles are presented in Fig. 6. We then calcu-
lated the diminution in cell-associated 160S particles
after 4 min of incubation at 37°C, taking into account
the percentage of cell-associated radioactivity remain-
ing after 4 min of elution (Fig. 5). Thus, at this time, the
percentages of 160S cell-associated particles con-
verted into internalized 135S particles were 35% for S1,
43% for S1(2Y), and 80% for S1(1I). This clearly indi-
cates that the differences in transition kinetics ob-
served between viruses were not only the result of the
elution process. The alteration ratio given in Fig. 6,
(the area under the 135S peak divided by the area
under the 160S peak) is a measure of the uncoating
transitions. The uncoating transitions of S1(1I) oc-
curred much faster (nearly complete 4 min after the
shift to 37°C) than those of S1 (Fig. 6). For each time
point, the alteration ratio was higher for S1(1I) than for
S1, indicating that this mutant undergoes the 160S to
135S transition more efficiently than does S1. The
alteration ratios of S1(2Y) were slightly higher than
those of S1.
The capacity of the point mutants to induce conforma-
tional changes more efficiently could be a consequence
of the instability of the mutant capsids. Thus, we deter-
mined the kinetics of thermal inactivation for the two
mutants, S1(1I) and S1(2Y), in comparison with S1, at
47.5°C. Surprisingly, these mutants exhibited a greater
thermostability than the S1 strain, since after only 6 min
at 47.5°C, the infectivity of S1(1I) and S1(2Y) was reduced
by 1.5 and 0.7 log ID50/ml, respectively, while that of S1
was reduced by 2.3 log ID50/ml. This relative thermosta-
bility of the mutants indicates that the capsids of the
point mutants are not inherently unstable.
FIG. 4. Kinetics of adsorption of S1, S11, S1/11-C1, S1(2Y-1I), S1(1I),
and S1(2Y) virions. HEp-2c cells were infected with radiolabeled virus
at 4°C. Unattached virus was removed at the indicated times and
cell-associated counts per minute were measured. The quantity of
cell-associated virus (in ID50) at each time point was calculated in
function of the specific activities of the radiolabeled viruses. The two
viruses S11 and S1/11-C1 which have the same capsids have the same
binding profiles despite the fact that they had different specific activi-
ties and can therefore be considered as internal controls for this
method. Each point represents the mean value of four separate exper-
iments and the standard errors of the means are indicated by vertical
bars.
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DISCUSSION
Very few determinants responsible for the establish-
ment of persistent infections in vitro have been identified
for RNA viruses, although a determinant involved in the
persistence of Sinbis virus in BHK21 cells has been
localized in a nonstructural protein (Dryga et al., 1997). In
the case of PVpi S11, viral determinants crucial in the
establishment of persistent PV infections in HEp-2c cell
cultures are localized in the capsid proteins (Calvez et
al., 1993). Our strategy to identify the PV determinants of
persistence was based on the observation that, during
persistent infection, PVpi tend to revert to the S1 geno-
type and to a phenotype more lytic in uninfected HEp-2c
cell cultures. After 2 to 3 months of persistent infection,
two true reversions were found at nucleotide positions
corresponding to PVpi mutations: one at nucleotide 1148
in the codon of amino acid 67 of VP2 and the second,
which decreased considerably the score of persistence,
at nucleotide 2957 in the codon of amino acid 160 of VP1
(Fig. 1A).
Two recombinant viruses, S1/11(2N-VP1) and S1/
11(VP2-1I), were constructed, which carried the (2N) de-
terminant in association with all of the S11 determinants
of VP1 and the (1I) determinant in association with all of
the S11 determinants of VP2, respectively. Both estab-
lished persistent infections. Thus, various combinations
of mutations may confer the ability to persistently infect
HEp-2c cell cultures to the S1 virus, suggesting that the
FIG. 5. Kinetics of elution of attached S1, S1/11-C1, S1(2Y-1I), S1(1I), and S1(2Y) particles. HEp-2c cells were infected with radiolabeled virus for 150
min at 4°C. Unattached virus was removed, and cells were incubated at 37°C. Eluted virus was removed at the indicated times, and cell-associated
counts per minute were measured. Time point values are expressed as a percentage of the total counts per minute attached prior to the 37°C
incubation. Each point represents the mean value of three separate experiments and the standard errors of the means are indicated by vertical bars.
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FIG. 6. Kinetics of the conversion of 160S virions into 135S particles as analyzed by sucrose gradient centrifugation. HEp-2c cells were infected
with radiolabeled S1, S1(1I), and S1(2Y) viruses for 150 min at 4°C. Unattached virus was removed, and cells were incubated at 37°C for the indicated
times. Cells were then lysed and cell-associated particles were sedimented through a 15 to 30% sucrose gradient. The gradients were fractionated
from the bottom, and fractions were counted for radioactivity. The alteration ratio 135S/160S is the area under the 135S peak divided by the area under
the 160S peak.
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lytic effect of a virus can be decreased in several ways.
We identified the VP2 determinants which, in the pres-
ence of the (1I) determinant of VP1, confered the pheno-
type of persistence to S1. Eight different point mutants
established persistent infections in HEp-2c cells (Fig. 2).
These point mutants, unlike S11 and S1/11-C1, carried no
silent mutations, thereby eliminating the role of these
mutations in the phenotype of persistence.
From the percentage of persistent infections estab-
lished with each of the point mutants, it appears difficult
to measure the effect of a single mutation independently
of the other mutations in the same virus. For example, the
(2N) determinant, which seemed favorable to persis-
tence in association with all of the S11 determinants of
VP1, had a neutral effect in the context of S1(2NY-1I) and
was unfavorable in the context of S1(2N-1I). However,
our results indicate that determinants (2V), (2Y), (2I), and
(1I) enhanced the score of persistent infections of some
of the point mutants described here (Fig. 2).
Most interestingly, each of two S11 determinants, (2Y)
and (1I), was sufficient to confer the phenotype of per-
sistence to S1 independently, although with a low effi-
ciency. The effect of these determinants was probably
cumulative since the virus carrying both determinants
established persistent infections more efficiently than
the viruses carrying only one or the other of these de-
terminants (Fig. 2). The difference between the frequency
at which persistent infections were established with PVpi
and the point mutants also suggests that several muta-
tions have a cumulative effect on the capacity of PVpi to
establish persistent infections.
The genome of PV, even after cloning, is considered to
be a mixture of quasi-species because of the high mu-
tation frequency (in the order of 1024) of the viral poly-
merase and of the absence of an appropriate correction
mechanism (Holland et al., 1982). This means that mu-
tants with an increased lytic capacity could emerge after
a single virus cycle in HEp-2c cells infected by a persis-
tent virus. In six cultures in which S1(2Y-1I) failed to
establish persistent infections, we did not observe rever-
sions of the PVpi mutations. This does not exclude the
possibility that the selection of other mutations else-
where in the viral genome contributed to the lysis of
these cultures. The emergence of suppressor mutations
could modify the phenotype of point mutants more easily
than that of PVpi harboring several mutations involved in
persistence. This could explain why the point mutants,
carrying only a few mutations, had a lower score of
persistence than PVpi S11.
It seems likely that stocks of the lytic S1 strain contain
a few persistent mutants and conversely that stocks of
PVpi contain a few lytic virus mutants because of the
quasi-species nature of the PV genome. We have previ-
ously shown that the lytic phenotype is dominant early in
the infection (Borzakian et al., 1992), and this could ex-
plain why a persistent infection was never obtained with
S1. In the case of PVpi and point mutants, the conditions
for the establishment of a persistent infection in HEp-2c
cell cultures require a very low m.o.i., and this could
allow the elimination of the lytic quasi-species by virus
dilution, which could be responsible for cell lysis at
higher m.o.i.
We have found that, when cells are infected at a very
low m.o.i. by persistent mutants, the ratio of virus to cell
in the culture rapidly increased during the first 2 days.
This must be due to a high level of virus replication which
kills most of the cells at this time. Even if many cells were
not infected during the first round of infection, they had
very little chance of escaping infection in the next 2 to 3
days, and resistant mutant cells could hardly be selected
in this short time. We propose that rare cells in the
culture, infected by only one or very few persistent viri-
ons, become resistant to superinfection by all viruses of
the yield, including emergent lytic quasi-species, and are
capable of growing as colonies. We observed that the
growth of such colonies could have successive periods
of crisis, suggesting that cell selection occurred in the
following weeks, after the establishment of the infection
by the persistent mutants.
As was suggested by the localization of both (1I) and
(2Y) determinants, our results indicate that they affect the
early steps of the virus cycle. First, these two determi-
nants enhanced the adsorption of S1(1I), S1(2Y), and
S1(2Y-1I) onto PVR, suggesting that the binding site on
the virus is better recognized by the cell receptor and/or
that the virus–receptor interaction is more stable. Sec-
ond, these two determinants modified, although to differ-
ent degrees, the kinetics of the receptor-mediated con-
formational changes leading to the formation of 135S
particles. The mutation (2Y) was responsible for a small
increase in the efficiency of the 160S to 135S conversion
(Fig. 6) while the mutation (1I) enhanced considerably
both the elution process and the 160S to 135S conver-
sion (Figs. 5 and 6). Even if the 135S particles are not
indispensible intermediates of infection as suggested by
recent data involving cold-adapted PV mutants (Dove
and Racaniello, 1997), our results indicate that the early
steps of the viral cycle are different for the persistent
point mutants when compared to the lytic S1 strain.
Consistent with this, each of the (2Y) and (1I) determi-
nants confers the capacity to overcome the block of PV
multiplication in the central nervous system of mice,
which involves an early step, to the Mahoney strain
(Colston and Racaniello, 1995; Couderc et al., 1994).
Capsid instability could have been responsible for the
facilitated uncoating transitions of the two point mutants
S1(2Y) and S1(1I), but it is improbable since their ther-
mostability was greater than that of the S1 strain. It
cannot be excluded that the increased intrinsic capsid
stability of the mutants play a role in the persistent
phenotype. It has recently been shown that in the context
of the wild-type Mahoney strain, the same (2Y) and (1I)
mutations facilitated the conversion to 135S particles in
vitro (Wien et al., 1997). This is in agreement with our
10 PELLETIER, DUNCAN, AND COLBE`RE-GARAPIN
results which show that conformational modifications
induced by the PVR are enhanced for our S1 point mu-
tants, further suggesting that the (2Y) and (1I) determi-
nants modify PV/PVR interactions. Indeed, for the S1(1I)
mutant, the elution process was considerably increased
and this could reduce the amount of infectious virus
capable of initiating a cycle of multiplication, despite the
advantage conferred by a more efficient uncoating. If the
PV-induced cytopathic effects are triggered by the virus–
receptor interactions, as previously proposed (Morrison
et al., 1994), it might also be possible that the two mu-
tations involved in the persistent phenotype modify the
cell lysis pathway.
The identification of precise viral determinants in-
volved in the persistent and lytic phenotypes are valu-
able tools for elucidating the mechanisms of virus per-
sistence. Although we have already described here
several effects of the two determinants (2Y) and (1I) on
the early steps of the viral cycle, we cannot exclude that
a postentry step may also be involved in PV type 1
persistent infection. The construction of all the point
mutants carrying each of the S11 determinants individu-
ally, together with the study of both their structure and
their growth cycles, will probably be necessary to further
clarify the mechanisms by which cells may survive in-
fection by a virus as lytic as PV.
MATERIALS AND METHODS
Cells and viruses
HEp-2c cells were grown in Dulbecco’s modified Ea-
gle’s medium (DMEM) containing 10% newborn calf se-
rum (NCS). The human neuroblastoma cell line IMR-32
was grown in DMEM with 10% fetal calf serum (FCS). We
used the PV type 1 strain LSc 2ab (S1) (Sabin and
Boulger, 1973) and a PVpi, S11, derived from S1 after 6
months of persistent infection in IMR-32 cells (Pelletier et
al., 1991). S1/11-C1 is a chimera of S1 and S11. It contains
a segment of the genome S11 from nt 905 to nt 3519,
corresponding to BanII sites in the cDNA (Calvez et al.,
1993). PVpi S11 and the recombinant S1/11-C1 could
establish persistent infections in HEp-2c cells (Calvez et
al., 1993; Pelletier et al., 1991). Viral stocks were prepared
on IMR-32 cells and their infectivity was titered by an
endpoint micromethod on both IMR-32 and HEp-2c cells
in 96-well plates. This technique was chosen rather than
that of plaques, because in liquid medium cytopathic
effects caused by PVpi can be seen under the micro-
scope despite the presence of growing cells. The infec-
tious titers are expressed per milliliter, as the log10 of the
highest virus dilution for which cytopathic effects and
cell lysis were observed in 50% of wells 7 days after
infection. The highest titer, on IMR-32 or HEp-2c cells,
was used to determine the concentration of virions.
Construction of S1/11 cDNAs containing mutations in
the capsid protein encoding region
For cDNA synthesis, we used AMV reverse tran-
scriptase (Boehringer Mannheim). VentR DNA Poly-
merase (New England Biolabs) was used for all PCRs
according to the manufacturer’s directions. The vec-
tors were treated with alkaline phosphatase (Boehr-
inger Mannheim) and ligated by a T4 DNA ligase
(Boehringer Mannheim). Recombinants containing the
insert were identified by restriction enzyme analysis
and/or by DNA sequencing with the DNA sequencing
kit (United States Biochemical). Viruses corresponding
to two cDNA clones for each construction were ob-
tained by independent transfection in neuroblastoma
IMR-32 cells by the calcium technique and both were
then used to test the persistent phenotype. Total cy-
toplasmic RNA from PV-infected IMR-32 cells (10 mg)
was used for sequencing with AMV reverse tran-
scriptase as previously described (Fichot and Girard,
1990). The nomenclature of the S1/11 cDNAs is given
in the legend to Fig. 1.
Construction of pS1/11-C1(1V). Total RNA was ex-
tracted from IMR-32 cells infected with a S1/11-C1 mu-
tant, isolated from infection (c) (see Results, first para-
graph) and containing the true reversion at nt 2957 (G).
This RNA was used to synthesize the viral cDNA which
was amplified by PCR and then a small fragment con-
taining the reversion was used to replace the corre-
sponding fragment in the previously described pS11-59
(Calvez et al., 1993). A fragment was excised from this
subclone and used to replace the corresponding frag-
ment in pVS(1)IC-O(T) (abbreviated here as pVS1) (Ko-
hara et al., 1986) (Fig. 1).
Construction of pS1/11-C1(2D), pS1/11(2N-VP1), pS1/
11(VP2-1I), and pS1(2N-1I). These constructions were
obtained either by exchanging DNA fragments between
pVS1 and pS1/11-C1 or by site-directed mutagenesis
using these same two plasmids as a template and ap-
propriate mutagenic primers or by a combination of both
methods (Fig. 1).
Construction of pS1(2NVYI-1I). A BsmI fragment (nt 456
to 1513) was excised from pS1/11-C1 and used to replace
the corresponding fragment in a subclone which carried
the cDNA fragment (nt 162–3560) from pS1(2N-1I) de-
scribed above. An AvaI fragment (nt 475 to 2978) was
excised from this plasmid named pS1-59-(2NVYI-1I) and
used to replace the corresponding fragment in pVS1
(Fig. 2).
Construction of pS1(2NI-1I), pS1(2NYI-1I), pS1(2NY-1I),
pS1(2VY-1I), and pS1(2Y-1I). For these five constructions,
nucleotide changes were introduced into pVS1 by a
strategy that used mutagenic and nonmutagenic primers
in a series of PCRs (Higushi, 1990). pS1(2N-1I) or pVS1
cDNA fragments were amplified with appropriate muta-
genic or nonmutagenic primers. In PCR No. 1, we used a
mutagenic primer containing a 1 base pair (bp) mismatch
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and a nonmutagenic primer to synthesize the upstream
fragment carrying the mutation. In PCR No. 2, we used a
mutagenic primer containing a 1-bp mismatch and a
nonmutagenic primer to synthesize the downstream
fragment carrying the mutation. Products from PCR No. 1
and No. 2 overlapped in the region of complementarity
between mutagenic primers and thus could be annealed
and used as the template in a third PCR performed with
nonmutagenic primers. The PCR products were digested
with appropriate enzymes and used to replace the cor-
responding fragments in pVS1 or the newly constructed
vectors harboring point mutations (Fig. 2).
Construction of pS1(2Y) and pS1(1I). These two con-
structions were performed by exchanging the AgeI–NheI
fragments (nt 339 to 2470) between pS1(2Y-1I) and pVS1
(Fig. 2).
Persistent infection in HEp-2c cell cultures
The phenotype of each PV S1/11 mutant was deter-
mined in HEp-2c cells at a m.o.i. of 1024 ID50 per cell,
cultured in DMEM containing 2% FCS in 25 cm2 flasks or
in 24-well plates. Five to seven days after infection,
surviving cells were grown in DMEM containing 10%
NCS, and this medium was changed once a week. Ex-
tensive cytopathic effects were observed during the first
2 weeks and then persistently infected cells were gen-
erally detected 2 to 5 weeks after infection. Cultures
were considered to be persistently infected when cells
had survived infection for at least 8 weeks while produc-
ing virus (Fig. 3). Persistent infections were scored as the
ratio of the number of cultures in which persistent infec-
tions were established to the number of infected cul-
tures. As previously reported (Borzakian et al., 1992;
Pelletier et al., 1991), the establishment of persistent
infections in HEp-2c cell cultures was highly dependent
on optimal conditions for cell growth, and this was par-
ticularly true for the point mutants described here.
Preparation of radiolabeled virions
Radiolabeled virions were prepared in HEp-2c cells
with [35S]methionine (1400 Ci/mmol; ICN) as previously
described (Pelletier et al., 1991) and purified by isopycnic
CsCl gradient centrifugation (Blondel et al., 1983). The
specific activities of S1, PVpi S11 and the persistent
mutants varied between 0.7 3 1024 and 4.7 3 1024
cpm/ID50 and these data were used to calculate the
amount of cell-associated virus (see Fig. 4). Furthermore,
in all experiments, the same inoculum (in ID50) was used
for each virus.
Binding assay
HEp-2c cells (2 3 106) in suspension were precooled
on ice for 10 min and then infected with [35S]methionine
labeled virions at a m.o.i. of 100 ID50/cell in 0.2 ml of
DMEM with 2% FCS (DMEM–FCS). At various times post
infection (0, 30, 60, 90, 120, 150, 180, and 210 min), cells
were washed twice with DMEM–FCS and once with
phosphate-buffered saline (PBS). All steps were per-
formed on ice with ice-cold medium or buffer. Cell-asso-
ciated radioactivity was then determined by scintillation
counting.
Elution kinetics
HEp-2c cells (2 3 106) in suspension were precooled
on ice for 10 min and then infected with [35S]methionine-
labeled virions at a m.o.i. of 100 ID50/cell in 0.2 ml of
ice-cold DMEM–FCS on ice for 150 min. Cells were then
washed twice with ice-cold DMEM–FCS and incubated
for various times (0, 4, 8, 15, 30, 60, and 90 min) in 3 ml
of DMEM–FCS preheated to 37°C. Cells were then
washed once with ice-cold PBS and the cell-associated
radioactivity was determined by scintillation counting.
Alteration of 160S to 135S particles
Precooled HEp-2c cells in suspension (107) were in-
fected with [35S]methionine-labeled virions at a m.o.i. of
100 ID50/cell in 2 ml of DMEM–FCS on ice for 150 min.
Cells were then washed twice in DMEM–FCS on ice.
Alterations were started by the addition of 5 ml of
DMEM–FCS preheated to 37°C and cells were incu-
bated for various times (0, 4, 8, and 15 min) at 37°C. Cells
were then washed successively with ice-cold DMEM–
FCS and PBS. Cell pellets were resuspended in 500 ml of
140 mM NaCl, 50 mM Tris–HCl, pH 8, 1% Nonidet P-40,
0.1% sodium dodecyl sulfate (SDS), and incubated on ice
for 20 min. Cell lysates were clarified by centrifugation in
a microfuge and an aliquot of 10 ml of each supernatant
was counted in order to confirm that the elution con-
corded with the results shown in Fig. 5. The remaining
supernatant was layered onto 15 to 30% sucrose gradi-
ents prepared in PBS. Gradients were centrifuged in a
Kontron TST41.14 rotor for 2 h at 40,000 rpm at 4°C and
fractionated into scintillation vials. The amount of 35S
label in each fraction was counted. Virions (160S) and
80S particles, previously purified by CsCl gradient cen-
trifugation, were layered onto parallel sucrose gradients
and used as sedimentation markers.
Thermostability of virus particles
Virus thermostability assays were performed as previ-
ously described (Couderc et al., 1996) with 108 particles
in PBS at 47.5°C for various times (0, 3, 6, and 9 min). The
infectious titer remaining after heat treatment was deter-
mined at 34°C on HEp-2c cells using the endpoint mi-
cromethod mentioned above.
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